'Consolidated
net sales (including other operating income) of Atul has increased 11.85% to Rs
1322.05 crore. Sales of Life Science
Chemicals segment has gone up 20.96% to Rs 423.63 crore (accounting for 30.66%
of total sales). Sales of Performance
& Other Chemicals segment has gone up 7.34% to Rs 938.62 crore (accounting
for 67.93% of total sales). Sales of
Others segment rose 65.76% to Rs 19.41 crore (accounting for 1.40% of total
sales). Inter-segment sales rose Rs
54.37 crore to Rs 59.61 crore.
Profit
before interest, tax and other unallocable items (PBIT) has jumped 12.63% to Rs
161.15 crore.
PBIT of Life Science
Chemicals segment rose 35.85% to Rs 70.97 crore (accounting for 44.04% of total
PBIT). PBIT of Performance & Other
Chemicals segment fell 4.35% to Rs 85.15 crore (accountin...
Pleaselogin & subscribe to view the full report.
More Reports
-
(01-Mar-2025)
Foseco India
OP up 17%
-
(28-Feb-2025)
Schaeffler India
Maintains double digit revenue growth and stable OPM
-
(28-Feb-2025)
Sanofi India
OP up 18.78%
-
(28-Feb-2025)
KSB
Net up 33% largely on higher sales, higher OI and lower taxation
|
|